{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:35:18Z","timestamp":1775147718101,"version":"3.50.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,24]]},"DOI":"10.7759\/cureus.70119","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T22:18:02Z","timestamp":1727216282000},"source":"Crossref","is-referenced-by-count":1,"title":["Discrepancy Between Liquid Biopsy and Tumor Next-Generation Sequencing Due to Low Tumor Fraction in a Patient With Lung Adenocarcinoma"],"prefix":"10.7759","author":[{"given":"Madeline C","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor A","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Pellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2020.01.005","article-title":"Liquid biopsies using circulating tumor DNA in non-small cell lung cancer","volume":"30","author":"Pellini B","year":"2020","unstructured":"Pellini B, Szymanski J, Chin RI, Jones PA, Chaudhuri AA. Liquid biopsies using circulating tumor DNA in non-small cell lung cancer. Thorac Surg Clin. 2020, 30:165-77. 10.1016\/j.thorsurg.2020.01.005","journal-title":"Thorac Surg Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/PO.22.00261","article-title":"Tumor fraction correlates with detection of actionable variants across > 23,000 circulating tumor DNA samples","volume":"6","author":"Husain H","year":"2022","unstructured":"Husain H, Pavlick DC, Fendler BJ, et al.. Tumor fraction correlates with detection of actionable variants across > 23,000 circulating tumor DNA samples. JCO Precis Oncol. 2022, 6:e2200261. 10.1200\/PO.22.00261","journal-title":"JCO Precis Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.09.163","article-title":"Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study","volume":"34","author":"Reichert ZR","year":"2023","unstructured":"Reichert ZR, Morgan TM, Li G, et al.. Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study. Ann Oncol. 2023, 34:111-20. 10.1016\/j.annonc.2022.09.163","journal-title":"Ann Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.4305","article-title":"Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer","volume":"5","author":"Aggarwal C","year":"2019","unstructured":"Aggarwal C, Thompson JC, Black TA, et al.. Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer. JAMA Oncol. 2019, 5:173-80. 10.1001\/jamaoncol.2018.4305","journal-title":"JAMA Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.51700","article-title":"Concurrent tissue and circulating tumor DNA molecular profiling to detect guideline-based targeted mutations in a multicancer cohort","volume":"7","author":"Iams WT","year":"2024","unstructured":"Iams WT, Mackay M, Ben-Shachar R, et al.. Concurrent tissue and circulating tumor DNA molecular profiling to detect guideline-based targeted mutations in a multicancer cohort. JAMA Netw Open. 2024, 7:e2351700. 10.1001\/jamanetworkopen.2023.51700","journal-title":"JAMA Netw Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/288262-discrepancy-between-liquid-biopsy-and-tumor-next-generation-sequencing-due-to-low-tumor-fraction-in-a-patient-with-lung-adenocarcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T22:18:04Z","timestamp":1727216284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/288262-discrepancy-between-liquid-biopsy-and-tumor-next-generation-sequencing-due-to-low-tumor-fraction-in-a-patient-with-lung-adenocarcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.70119","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,24]]}}}